From Casetext: Smarter Legal Research

Pharma v. Sun Pharmaceutical Indus

United States Court of Appeals, Federal Circuit
Feb 4, 2011
408 F. App'x 362 (Fed. Cir. 2011)

Opinion

No. 2011-1095.

February 4, 2011.

Appeal from the United States District Court for the District of Delaware in case no. 09-CV-0630, Chief Judge Gregory M. Sleet.

ON MOTION


ORDER

The appellants move without opposition to stay proceedings in this appeal pending the court's disposition in Aventis Pharma S.A. v. Hospira Inc., 2011-1018, -1047, and separately move for an extension of time to file their initial brief.

Upon consideration thereof,

IT IS ORDERED THAT:

(1) The motion to stay the briefing schedule is granted. The appellants are directed to inform this court, within 14 days of the issuance of this court's mandate in 2011-1018, -1047, concerning how they believe that this appeal should proceed. The appellees may also respond within that time.

(2) The motion for an extension of time is denied as moot.


Summaries of

Pharma v. Sun Pharmaceutical Indus

United States Court of Appeals, Federal Circuit
Feb 4, 2011
408 F. App'x 362 (Fed. Cir. 2011)
Case details for

Pharma v. Sun Pharmaceutical Indus

Case Details

Full title:AVENTIS PHARMA SA and SanofiAventis U.S., LLC, Plaintiffs-Appellants, v…

Court:United States Court of Appeals, Federal Circuit

Date published: Feb 4, 2011

Citations

408 F. App'x 362 (Fed. Cir. 2011)